Deirdre M. Boucherie

Rotterdam, ZH 3000CA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Unraveling the paradox: cardiovascular risk profiling in migraine- a correspondence.

Unraveling the paradox: cardiovascular risk profiling in migraine- a correspondence.

Journal: The journal of headache and pain

Published: April 24, 2025

Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'.

Author response to 'Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications'.

Journal: Cephalalgia : an international journal of headache

Published: October 24, 2024

Migraine in men.

Migraine in men.

Journal: The journal of headache and pain

Published: October 15, 2024

Sex differences in CGRP-induced vasodilation of human middle meningeal arteries but not human coronary arteries: implications for migraine.

Sex differences in CGRP-induced vasodilation of human middle meningeal arteries but not human coronary arteries: implications for migraine.

Journal: Cephalalgia : an international journal of headache

Published: July 23, 2024

Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics.

Comparison of gepant effects at therapeutic plasma concentrations: connecting pharmacodynamics and pharmacokinetics.

Journal: The journal of headache and pain

Published: July 17, 2024

Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?

Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?

Journal: Cephalalgia : an international journal of headache

Published: May 26, 2024

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol.

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention - part 4: propranolol.

Journal: The journal of headache and pain

Published: March 09, 2024

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate.

Journal: The journal of headache and pain

Published: August 25, 2023

Blocking the CGRP Receptor: Differences across Human Vascular Beds.

Blocking the CGRP Receptor: Differences across Human Vascular Beds.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 05, 2023

Future targets for migraine treatment beyond CGRP.

Future targets for migraine treatment beyond CGRP.

Journal: The journal of headache and pain

Published: December 31, 2022

Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis.

Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis.

Journal: The journal of headache and pain

Published: December 29, 2022

The sense of stopping migraine prophylaxis.

The sense of stopping migraine prophylaxis.

Journal: The journal of headache and pain

Published: December 28, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026